Needle-Free Injection System Market Estimated To Experience A Hike In Growth By 2026| Antares Pharma, Endo Pharmaceuticals Inc., PharmaJet, Inovio Pharmaceuticals, Inc

Global needle-free injection system market is expected to reach USD 42.63 Billion by 2026 and set to witness a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to extensive use of needle-free injection system in the developing countries.

The reactions of consumers to a product already existing in the market can be known with this global needle-free injection system report. Moreover, this market report gives idea to clients about the market drivers and restraints extracted from SWOT analysis and also provides all the CAGR projections for the historic year 2016, base year 2017 and forecast period of 2018-2025. Market analysis included here gives an examination of various segments that are relied upon to witness the fastest development amid the estimate forecast frame. And not to mention, before giving it to the end users, all this information is assessed and validated by the market experts.

Get Sample Copy Of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-needle-free-injection-system-market

Few of the major competitors currently working in global needle-free injection system market are Antares Pharma, Endo Pharmaceuticals Inc., PharmaJet, Inovio Pharmaceuticals, Inc., Medical International Technologies, INJEX, THE NATIONAL MEDICAL PRODUCTS CO., LTD, Valeritas, Inc., InsuJet, PenJet, Crossject, Amico Group, BD, Inovio Pharmaceuticals, Inc., MedImmune, Mystic Pharmaceuticals, OptiNose US, Inc., Zogenix, D'Antonio Consultants International, Inc., among others.

Key Developments in the Market:

In July 2019, Eli Lilly and Company has received U.S. Food and Drug Administration approval for Baqsimi (glucagon) nasal powder 3 mg. The product is used to treat diabetic severe hypoglycemia. The product approval will help company to increase its revenue generation from drug delivery system as the product is first of its kind and only nasally-dosed glucagon, available for diabetics
In January 2018, LenisUSA.com and Lenis Medical Ltd has formed partnership with Premier Media Service Inc. for distribution and sales of LENIS Needle-Free Injection System in U.S. The injection system is a next generation needle free injections system and the device is highly adaptable, and applicable to anesthetics, steroids, HA, HGH, HCG, MS drugs, vitamins, insulin, vaccines, filers, fertility drugs, and orthopedic drugs. The partnership will help company to increase its market presence in U.S.

Competitive Analysis:

Global needle-free injection system market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of needle-free injection system market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Drivers

Increasing number of chronic disease is expected to drive the growth of the market in the forecasted period
Increased rate of communicable disease due to needle stick injuries is expected to drive the growth of the market Increasing demand for self-injection devices is expected to increase growth of the market in the forecasted period


Increasing demand for biosimilars and vaccination is expected to enhance growth of the market

Market Restraints

Limitation in intravenous administration is expected to restrain the market growth
Stringent regulation is expected to hinder the market growth
Needle-free injection system is costly which is expected to restrain the market growth

Inquiry For Customize Report With Discount at : https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-needle-free-injection-system-market

Segmentation: Global Needle-Free Injection System Market

By Type

Liquid-Based Needle-Free Injectors
Projectile/Depot-Based Needle-Free Injectors
Powder-Based Needle Free Injectors

By Product

Fillable Needle-Free Injectors
Prefilled Needle-Free Injectors

By Technology

Jet-Based Needle-Free Injectors
Spring-Based Needle-Free Injectors
Laser-Powered Needle-Free Injectors
Vibration-Based Needle-Free Injectors

By Source of Power

Spring-Based Needle-Free Injectors
Gas Propelled/ Air Forced Injector Systems

By Usability

Disposable Needle-Free Injectors
Reusable Needle-Free Injectors
By Delivery Site

Subcutaneous Injectors
Intramuscular Injectors
Intradermal Injectors

By Application

Vaccine Delivery
Insulin Delivery
Oncology
Pain Management
Others

By End User

Hospitals
Clinics
Home Care Settings
Research Laboratories
Pharmaceutical and Biotechnological Companies
Others

By Geography

North America
South America
Europe
Asia-Pacifi
Middle East & Africa

Get Full Table Of content @ https://www.databridgemarketresearch.com/toc/?dbmr=global-needle-free-injection-system-market

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.